Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de David Evander Anderson
Age : 51
Public asset : 119,753 USD
Linked companies : VBI Vaccines Inc.
Summary 
Founder of Variation Biotechnologies (US), Inc. and Variation Biotechnologies, Inc. (Canada), David Evander Anderson currently is Chief Scientific Officer for VBI Vaccines, Inc. and Chief Scientific Officer at VBI Vaccines (Delaware), Inc. (a subsidiary of VBI Vaccines, Inc.).

He previously occupied the position of Vice President-Immunology & Research at Variation Biotechnologies (US), Inc., Chief Scientific Officer & Senior VP-Research at VBI Vaccines, Inc. and Assistant Professor at Harvard Medical School.

He received a doctorate from Harvard University and an undergraduate degree from the University of California, Davis.


Current positions of David Evander Anderson 
NameTitle Since
VBI Vaccines Inc.
(Biotechnology & Medical Research)
Chief Scientific Officer 2016
VBI Vaccines (Delaware), Inc. Chief Scientific Officer 2015


Holdings of David Evander Anderson 
NameEquities%Valuation
VBI Vaccines Inc. (VBIV)
(Biotechnology & Medical Research)
148,2090.057%119,753 USD


David Evander Anderson: Personal Network 
Most Read News 
07/29MARK ZUCKERBERG : Company's pandemic-era forecast was too rosy
RE
07/29CATHIE WOOD : Wood's ARK fund on track for first monthly gain since Oct as risky stocks rally
RE
08/06ELON MUSK : Musk says Twitter deal should go ahead if it provides proof of real accounts
RE
08/04JACK DORSEY : Dorsey-led Block posts loss for second quarter
RE
08/02ELON MUSK : Twitter queries banks on Musk's attempts to undermine $44 billion deal
RE
08/09ELON MUSK : Elon Musk sells 7.92 million Tesla shares worth $6.9 billion - SEC filing
RE
07/28JACK MA : Jack Ma plans to give up control of Ant Group - WSJ
RE
08/01DAVID EINHORN : Einhorn's Greenlight takes stake in Twitter - letter
RE
08/02STEPHEN KING : Horror author Stephen King says in publishing trial that consolidation hurts competition
RE
08/01STEPHEN KING : Stephen King goes to bat for U.S. gov't in case against book publishing mega-merger
RE
More news


© 2022 People and Ownership :   
David Evander Anderson : Connections